ArticleInternational journal of molecular sciences2026
Secreted Phosphoprotein 1 (SPP1) Modulates Intracellular Metabolic Programs in Mature Adipocytes Revealed by Untargeted Metabolomics.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Untargeted metabolomics of mature sorghum [Frontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Secreted phosphoprotein 1 (SPP1), also known as osteopontin (OPN), is a multifunctional secreted factor implicated in inflammatory remodeling of adipose tissue. Here, we applied untargeted liquid chromatography-mass spectrometry (LC-MS)-based metabolomics to examine how different concentrations of SPP1 influence metabolism in differentiated 3T3-L1 adipocytes. We found that low-dose SPP1 (100 ng/mL) was associated with more pronounced intracellular metabolic remodeling than higher-dose SPP1 (500 ng/mL). Multivariate analyses, including principal component analysis (PCA), partial least squares-discriminant analysis (PLS-DA), and sparse PLS-DA, revealed a distinct metabolic profile in the low-dose group, whereas the high-dose group showed a comparatively attenuated metabolic response. Pathway enrichment analysis identified alterations in carbohydrate- and amino acid-related metabolic networks, including the pentose phosphate pathway; pentose and glucuronate interconversions; and alanine, aspartate, and glutamate metabolism. In contrast, higher-dose SPP1 was associated with selective induction of matrix metalloproteinase-12 (MMP-12), suggesting the engagement of remodeling-associated responses at elevated SPP1 levels. Together, these findings identify SPP1 as a modulator of metabolic programs in mature adipocytes and highlight its capacity to influence intracellular metabolic remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.